Group structure
11 companies in 6 countries
Ireland1
Netherlands1
United Kingdom1
1 more country
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 40
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANAPEN 0,15 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA0,15 mg · Solución inyectable en jeringa precargada | Epinephrine | Spain | Marketed | 2012 |
| ANAPEN 0,30 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA0,30 mg · Solución inyectable | Epinephrine | Spain | Marketed | 2012 |
| ANAPEN 0,50 MG/0,3 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA1,872 mg · Solución inyectable en jeringa precargada | Epinephrine | Spain | Marketed | 2019 |
| Anapen junior, oplossing voor injectie 0,15 mg/dosisOplossing voor injectie | Epinephrine | Netherlands | Authorised | 2005 |
| Anapen, oplossing voor injectie 0,3 mg/dosisOplossing voor injectie | Epinephrine | Netherlands | Authorised | 2005 |
| CHENPENSoluzione iniettabile | Epinephrine | Italy | Authorised | |
| Hidrasec 10 mg, granulaat voor orale suspensieGranulaat voor orale suspensie | Acetorphan | Netherlands | Authorised | 2011 |
| Hidrasec 10 mg granule za oralnu suspenzijugranule za oralnu suspenziju | Acetorphan | Croatia | Marketed | 2018 |
| HIDRASEC 100 MG CAPSULAS DURAS100 mg · Cápsula dura | Acetorphan | Spain | Marketed | 2013 |
| Hidrasec 100 mg, capsules hardCapsule, hard | Acetorphan | Netherlands | Authorised | 2011 |
| Hidrasec 175 mg, filmomhulde tablettenFilmomhulde tablet | Acetorphan | Netherlands | Authorised | 2018 |
| Hidrasec 30 mg, granulaat voor orale suspensieGranulaat voor orale suspensie | Acetorphan | Netherlands | Authorised | 2011 |
| Hidrasec 30 mg granule za oralnu suspenzijugranule za oralnu suspenziju | Acetorphan | Croatia | Marketed | 2018 |
| Hidrasec effect 100 mg tvrde kapsulekapsula, tvrda | Acetorphan | Croatia | Marketed | 2018 |
| Ozawade | Pitolisant | EU (EMA) | Authorised | 2021 |
| OZAWADECompressa rivestita con film | Pitolisant | Italy | Authorised | |
| OZAWADE 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Pitolisant | Spain | Authorised | 2021 |
| Ozawade 18 mg filmomhulde tablettenFilmomhulde tablet | Pitolisant | Netherlands | Authorised | 2021 |
| OZAWADE 4,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto con película | Pitolisant | Spain | Authorised | 2021 |
| Ozawade 4.5 mg filmomhulde tablettenFilmomhulde tablet | Pitolisant | Netherlands | Authorised | 2021 |
| SIMEGUTGocce orali, emulsione | Dimethicone | Italy | Authorised | |
| TIORFANSospensione orale | Acetorphan | Italy | Authorised | |
| TIORFAN 100 mg CAPSULAS DURAS100 mg · Cápsula dura | Acetorphan | Spain | Marketed | 2026 |
| TIORFAN 100 mg CAPSULAS DURAS100 mg · Cápsula dura | Acetorphan | Spain | Marketed | 2000 |
| TIORFAN LACTANTES 10 mg GRANULADO PARA SUSPENSION ORAL10 mg · Granulado para suspensión oral | Acetorphan | Spain | Marketed | 2002 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 14 | 13 | 1 | CompaniesAll medicines |
| Netherlands | 10 | 10 | 0 | CompaniesAll medicines |
| Italy | 7 | 7 | 0 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
| Croatia | 3 | 3 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of France, United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antidiarrhoeals and intestinal anti-infectivesAlimentary tract and metabolism · ATC A07X
- Other nervous system drugsNervous system · ATC N07X
- Cardiac therapyCardiovascular system · ATC C01C
- Drugs for functional gastrointestinal disordersAlimentary tract and metabolism · ATC A03A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- bioprojet europe
- bioprojet ferrer
- bioprojet italia
- bioprojet pharma 9 rue rameau pariz
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
All 14 sources
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Pharmaceutical group
- Companies
- 11
- Medicines
- 40
- Countries
- 6